Lunch symposium #2: Relugolix Combination Therapy, the 1st GnRH Antagonist in Europe for the management of Uterine Fibroids

• Relugolix Combination Therapy in women with symptomatic uterine fibroids, Ayman Al-Hendy (USA)
• Management of Bone Mineral Density in Pre-Menopausal Women, Peyman Hadji (Germany)